Electrophysiological Effects of Potential QT Prolonging Drugs
Conditions:   Drug-induced QT Prolongation;   Pharmacokinetics;   Pharmacodynamics Interventions:   Drug: Clarithromycin;   Drug: Pimozide;   Drug: Placebo (Part 1);   Drug: Moxifloxacin;   Drug: Cobicistat;   Drug: Moxifloxacin and Cobicistat;   Drug: Placebo (Part 2) Sponsors:   Food and Drug Administration (FDA);   Spaulding Clinical Research LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials

Electrophysiological Effects of Potential QT Prolonging Drugs
Conditions:   Drug-induced QT Prolongation;   Pharmacokinetics;   Pharmacodynamics Interventions:   Drug: Clarithromycin;   Drug: Pimozide;   Drug: Placebo;   Drug: Moxifloxacin;   Drug: Cobicistat;   Drug: Moxifloxacin and Cobicistat Sponsors:   Food and Drug Administration (FDA);   Spaulding Clinical Research LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2023 Category: Research Source Type: clinical trials

Thorough QT/QTc of Pritelivir in Healthy Subjects
Condition:   HSV Infection Interventions:   Drug: Pritelivir and moxifloxacin placebo;   Drug: Pritelivir placebo, moxifloxacin and moxifloxacin placebo;   Drug: Pritelivir placebo, moxifloxacin placebo and moxifloxacin Sponsor:   AiCuris Anti-infective Cures AG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2023 Category: Research Source Type: clinical trials